Author

A.-L. Keller

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Hartkopf· 1 shared A. Koch· 1 shared A. Staebler· 1 shared B. Gierke· 1 shared C. Schmees· 1 shared K. Schenke-Layland· 1 shared M. Pawlak· 1 shared N. Anderle· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Hartkopf

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A platform of patient-derived microtumors identifies therapeutic vulnerabilities in ovarian cancer.

N. Anderle, A. Koch, B. Gierke, A.-L. Keller, A. Staebler, A. Hartkopf, S. Brucker, M. Pawlak, K. Schenke-Layland, C. Schmees

This paper develops a 3D patient-derived microtumor platform to identify therapeutic vulnerabilities in ovarian cancer by testing drug responses and immune cell interactions.

bioRxiv · Nov 10, 2021 · PreprintCancer Biology